Single nucleotide polymorphisms in Plasmodium falciparum V type H+ pyrophosphatase gene (pfvp2) and their associations with pfcrt and pfmdr1 polymorphisms

https://doi.org/10.1016/j.meegid.2014.03.004Get rights and content

Highlights

  • First report on pfvp2 SNPs and their possible associations with pfcrt and pfmdr1.

  • Pfvp2 V405, K582 and P711 alleles were predominant in all eight countries studied.

  • Pfvp2 405I, 582R and 711S were mainly seen in areas where CQ resistance was uncommon.

  • There was an association between the pfvp2 VKP haplotype and CQ resistance pfcrt 76T.

Abstract

Background

Chloroquine resistance in Plasmodium falciparum malaria has been associated with pfcrt 76T (chloroquine resistance transporter gene) and pfmdr1 86Y (multidrug resistance gene 1) alleles. Pfcrt 76T enables transport of protonated chloroquine out of the parasites digestive vacuole resulting in a loss of hydrogen ions (H+). V type H+ pyrophosphatase (PfVP2) is thought to pump H+ into the digestive vacuole. This study aimed to describe the geographic distribution of single nucleotide polymorphisms in pfvp2 and their possible associations with pfcrt and pfmdr1 polymorphisms.

Methods

Blood samples from 384 patients collected (1981–2009) in Honduras (n = 35), Colombia (n = 50), Liberia (n = 50), Guinea Bissau (n = 50), Tanzania (n = 50), Iran (n = 50), Thailand (n = 49) and Vanuatu (n = 50) were analysed. The pfcrt 72–76 haplotype, pfmdr1 copy numbers, pfmdr1 N86Y and pfvp2 V405I, K582R and P711S alleles were identified using PCR based methods.

Results

Pfvp2 was amplified in 344 samples. The pfvp2 allele proportions were V405 (97%), 405I (3%), K582 (99%), 582R (1%), P711 (97%) and 711S (3%). The number of patients with any of pfvp2 405I, 582R and/or 711S were as follows: Honduras (2/30), Colombia (0/46), Liberia (7/48), Guinea-Bissau (4/50), Tanzania (3/48), Iran (3/50), Thailand (1/49) and Vanuatu (0/31). The alleles were most common in Liberia (P = 0.01) and Liberia + Guinea-Bissau (P = 0.01). The VKP haplotype was found in 189/194 (97%) and 131/145 (90%) samples harbouring pfcrt 76T and pfcrt K76 respectively (P = 0.007).

Conclusions

The VKP haplotype was dominant. Most pfvp2 405I, 582R and 711S SNPs were seen where CQ resistance was not highly prevalent at the time of blood sampling possibly due to greater genetic variation prior to the bottle neck event of spreading CQ resistance. The association between the pfvp2 VKP haplotype and pfcrt 76T, which may indicate that pfvp2 is involved in CQ resistance, should therefore be interpreted with caution.

Introduction

Plasmodium falciparum has persisted as a major cause of human suffering and death despite the deployment of antimalarial drugs. A contributing factor has been the development of resistance to antimalarial drugs such as chloroquine (CQ). For example, CQ resistance was associated with 2–6-fold increase in malaria attributed mortality (Trape, 2001). Thus, reports of developing tolerance to currently recommended artemisinin based combination therapies are of major concern (Dondorp et al., 2009, Noedl et al., 2008) and an understanding of the mechanisms of drug resistance in the malaria parasite is crucial.

Resistance to CQ appears to have developed independently in Colombia, Venezuela, Thai–Cambodian border, Papua New Guinea and the Philippines (Mita et al., 2009, Wootton et al., 2002). The P. falciparum chloroquine resistance transporter (pfcrt) gene appears to be the main determinant of CQ resistance. Specific haplotypes at positions 72–76 are linked to the regional evolution of CQ resistance (Awasthi and Das, 2013, Mita et al., 2009, Wootton et al., 2002) and the 76T allele is essential for resistance (Djimde et al., 2001, Plowe, 2003). Resistance has also been linked to the N86Y allele of the multidrug resistance gene 1 (pfmdr1) (Babiker et al., 2001). Resistance to CQ is associated with a loss of inherent fitness (Ord et al., 2007). It is therefore probable that compensatory mutations have evolved in P. falciparum over time as have been shown to occur in drug resistant bacteria (Jiang et al., 2008, Levin et al., 2000).

Pfcrt is located in the membrane of the digestive vacuole (DV) (Valderramos and Fidock, 2006) and transports protonated CQ down its electrochemical gradient out of the DV (Martin et al., 2009, Sanchez et al., 2007). This result in a loss of Hydrogen ions (H+) that must be replaced if the pH is to be maintained. Thus, the transport of H+ into the DV most probably increases when CQ is being removed. In line with this, a 10-fold increased transcription of a putative H+ pump located in the DV membrane has been observed in P. falciparum exposed to CQ and a 2-fold increase when exposed to lumefantrine (Jiang et al., 2008, Mwai et al., 2012). The putative pump is a V type H+ pyrophosphatase (PfVP2), which constitutes a novel class of H+ pump found in plants and some protozoa (Luo et al., 1999, McIntosh et al., 2001, McIntosh and Vaidya, 2002, Saliba et al., 2003). The aim of this study was to explore the role of the pfvp2 gene in antimalarial drug resistance by analysing single nucleotide polymorphisms (SNPs) in pfvp2 and their prevalence in eight different countries and possible association with polymorphisms in pfcrt and pfmdr1.

Section snippets

Biological material

Blood samples were collected from children and adults with symptomatic or asymptomatic P. falciparum mono infections, verified by microscopy, as part of clinical studies or community based cross sectional surveys. Details of these studies are reported elsewhere (Bjorkman et al., 1986, Jovel et al., 2011, Kofoed et al., 2007, Malmberg et al., 2013, Ursing et al., 2006, Veiga et al., 2011) and submitted for publication (Colombia study). Samples were chosen from available regions representing

Results

Pfvp2 was successfully amplified by PCR in 344/384 (90%) patient samples. Frequencies and geographic distribution of pfvp2 V405I, K582R and P711S are shown in Table 2. The VKP alleles were predominant with frequencies >85% in all countries. Alleles 405I + 711S were found together in 6/344 (1.7%) patient samples. All other pfvp2 405I, 582R and 711S SNPs were identified in separate patient samples.

Pfcrt K76T and pfmdr1 N86Y alleles were successfully amplified in 367/385 (95%) and 358/385 (93%)

Discussion

Studies have previously indicated that PfVP2 may be involved in resistance to CQ and lumefantrine (Jiang et al., 2008, Mwai et al., 2012). We therefore assessed the proportion of SNPs in pfvp2 and their association to polymorphism in pfcrt and pfmdr1. This is, to our knowledge, the first such report. The most striking result was the lack of variation of the pfvp2 alleles studied. Only 26 SNPs in 20 samples were found among 344 samples (including sequencing of approximately 15% of the gene)

Acknowledgments

This work was supported by Swedish International Development Cooperation Agency, Department for research Cooperation (Sida-SAREC Contribution no 75007082/03) and Sigurd och Elsa Goljes Minne Fund (project No. LA2010-0537). MIV is recipient of Post Doctoral fellowship from Fundação para a Ciência e Tecnologia (FCT)/ Ministerio da Ciência e Ensino Superior, Portugal – MCES (ref. SFRH/BPD/76614/2011). JU has a postdoctoral position funded by Stockholms läns landsting.

References (34)

  • S.G. Valderramos et al.

    Transporters involved in resistance to antimalarial drugs

    Trends Pharmacol. Sci.

    (2006)
  • M.I. Veiga et al.

    Multiplex PCR-RFLP methods for pfcrt, pfmdr1 and pfdhfr mutations in Plasmodium falciparum

    Mol. Cell. Probes

    (2006)
  • C. Aurrecoechea et al.

    PlasmoDB: a functional genomic database for malaria parasites

    Nucleic Acids Res.

    (2009)
  • G. Awasthi et al.

    Genetics of chloroquine-resistant malaria: a haplotypic view

    Mem. Inst. Oswaldo Cruz

    (2013)
  • H.A. Babiker et al.

    High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1

    J. Infect. Dis.

    (2001)
  • A. Bjorkman et al.

    Monthly antimalarial chemotherapy to children in a holoendemic area of Liberia

    Ann. Trop. Med. Parasitol.

    (1986)
  • A. Bjorkman et al.

    Susceptibility of Plasmodium falciparum to chloroquine in northern Liberia after 20 years of chemosuppression and therapy

    Ann. Trop. Med. Parasitol.

    (1985)
  • View full text